181 related articles for article (PubMed ID: 25400836)
1. [Lingua villosa nigra after chemotherapy].
Lkhoyaali S; Errihani H
Pan Afr Med J; 2014; 18():69. PubMed ID: 25400836
[No Abstract] [Full Text] [Related]
2. CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphoma.
Fisher RI
Important Adv Oncol; 1990; ():217-25. PubMed ID: 2182520
[No Abstract] [Full Text] [Related]
3. Hope for very elderly patients with diffuse large B-cell lymphoma.
Ribera JM
Lancet Oncol; 2011 May; 12(5):412-3. PubMed ID: 21482185
[No Abstract] [Full Text] [Related]
4. The clinician's decision of whether CHOP chemotherapy should be standard therapy for treatment of patients with diffuse histiocytic lymphoma.
Connors JM
Important Adv Oncol; 1990; ():227-33. PubMed ID: 2182521
[No Abstract] [Full Text] [Related]
5. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
[TBL] [Abstract][Full Text] [Related]
6. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
7. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
[TBL] [Abstract][Full Text] [Related]
8. Oral CHOP-like chemotherapy in 60-80 years-old patients with diffuse large B-cell lymphoma.
Guidez S; Lacotte-Thierry L; Tomowiak C; Princet I; Dreyfus B; Olivier G; Fleck E; Corby A; Motard C; Barrier J; Machet A; Le Dû K; Debiais-Delpech C; Chabin M; Leleu X; Guilhot J; Delwail V
Br J Haematol; 2019 Sep; 186(6):e175-e178. PubMed ID: 31309541
[No Abstract] [Full Text] [Related]
9. Large gastrosplenic fistula after effective treatment of abdominal diffuse large-B-cell lymphoma.
Palmowski M; Zechmann C; Satzl S; Bartling S; Hallscheidt P
Ann Hematol; 2008 Apr; 87(4):337-8. PubMed ID: 17929016
[No Abstract] [Full Text] [Related]
10. Hidden superpower.
McGuirt J
JAAPA; 2019 May; 32(5):66. PubMed ID: 31033720
[No Abstract] [Full Text] [Related]
11. [Cutaneous presentation of plasmablastic lymphoma in a patient with HIV Infection].
Zaragoza V; Martínez L; Pérez-Ferriols A; Alegre V
Actas Dermosifiliogr; 2008 Dec; 99(10):820-1. PubMed ID: 19091226
[No Abstract] [Full Text] [Related]
12. Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy.
Yokoo M; Kojima K; Sano H; Kai K; Arakawa F; Ohshima K; Matsunaga T; Kimura S
Ann Hematol; 2019 Jun; 98(6):1501-1503. PubMed ID: 30406822
[No Abstract] [Full Text] [Related]
13. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Peyrade F; Jardin F; Thieblemont C; Thyss A; Emile JF; Castaigne S; Coiffier B; Haioun C; Bologna S; Fitoussi O; Lepeu G; Fruchart C; Bordessoule D; Blanc M; Delarue R; Janvier M; Salles B; André M; Fournier M; Gaulard P; Tilly H;
Lancet Oncol; 2011 May; 12(5):460-8. PubMed ID: 21482186
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
15. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M;
Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120
[TBL] [Abstract][Full Text] [Related]
17. Neutropenic fever following chemotherapy in a patient with lymphoma.
Book L
Oncol Nurs Forum; 2008 Nov; 35(6):885-7. PubMed ID: 18980919
[No Abstract] [Full Text] [Related]
18. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
Akhtar S; Maghfoor I
N Engl J Med; 2002 Jun; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
[No Abstract] [Full Text] [Related]
19. Intraocular lymphoma as relapse after chemotherapy for primary breast diffuse large B-cell lymphoma.
Matsuo T; Tanaka T; Yano T
J Clin Exp Hematop; 2018 Dec; 58(4):180-183. PubMed ID: 30416173
[No Abstract] [Full Text] [Related]
20. Comorbidity is an independent prognostic factor in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP: a population-based cohort study.
Wieringa A; Boslooper K; Hoogendoorn M; Joosten P; Beerden T; Storm H; Kibbelaar RE; Veldhuis GJ; van Kamp H; van Rees B; Kluin-Nelemans HC; Veeger NJ; van Roon EN
Br J Haematol; 2014 May; 165(4):489-96. PubMed ID: 24754632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]